Pathophysiology and prevention of sudden cardiac death

Vineet Goyal1, Davinder S Jassal1,2, Naranjan S Dhalla1

  • 1a Institute of Cardiovascular Sciences, St. Boniface Hospital Albrechtsen Research Centre, 351 Tache Avenue, Department of Physiology and Pathophysiology, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB R2H 2A6, Canada.

Insights

Sudden cardiac death (SCD) stems from various heart diseases, potentially unified by sympathetic nervous system overactivity. Diagnosis and prevention involve advanced imaging, medical treatments, and invasive procedures.

Area of Science:

  • Cardiology
  • Pathophysiology
  • Medical Science

Background:

  • Sudden cardiac death (SCD) is a critical outcome across diverse cardiovascular diseases.
  • Each underlying condition presents unique etiologies and pathophysiological mechanisms.
  • A common pathway may involve sympathetic nervous system (SNS) overstimulation and elevated catecholamines.

Purpose of the Study:

  • To review the diverse etiologies of sudden cardiac death.
  • To explore a potential unifying pathophysiological mechanism for SCD.
  • To outline diagnostic and therapeutic strategies for SCD prevention.

Main Methods:

  • Review of existing literature on sudden cardiac death.
  • Analysis of diagnostic techniques including electrocardiography, echocardiography, MRI, and cardiac catheterization.
  • Examination of medical and invasive treatment modalities for SCD prevention.

Main Results:

  • Identified multiple etiologies for SCD, including arrhythmias, coronary artery disease, cardiomyopathies, and valvular stenosis.
  • Proposed sympathetic nervous system activation and catecholamine surge as a unifying mechanism.
  • Detailed various diagnostic tools and therapeutic interventions.

Conclusions:

  • Sudden cardiac death is multifactorial, with sympathetic overactivity as a potential common link.
  • Comprehensive diagnostic approaches are essential for risk stratification.
  • A combination of medical and invasive therapies can aid in SCD prevention.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
697
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.9K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.9K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
955
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
552
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.6K